CAS 959551-10-1

Fórmula: C20H14F3N3S

InChI: InChI=1S/C20H14F3N3S/c21-20(22,23)16-9-3-1-7-14(16)19-25-17-10-4-2-8-15(17)18(26-19)24-12-13-6-5-11-27-13/h1-11H,12H2,(H,24,25,26)

Chave InChI: QBDAEJRHUCSSPR-UHFFFAOYSA-N

SMILES: C1=CC=C(C(=C1)C2=NC3=CC=CC=C3C(=N2)NCC4=CC=CS4)C(F)(F)F

NIH-12848

CAS: 959551-10-1

NIH-12848

Fórmula: C₂₀H₁₄F₃N₃S

Pureza: 99.5%

Peso molecular: 385.41

Ref: 54-BUP13042

NIH-12848

CAS: 959551-10-1

NIH-12848 is a putative inhibitor of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) with an IC50 of 1 μM.

Fórmula: C₂₀H₁₄F₃N₃S

Pureza: 99.87% - 99.9%

Cor e Forma: Solid

Peso molecular: 385.405

Ref: TM-T3556

N-(Thiophen-2-ylmethyl)-2-(2-(trifluoromethyl)phenyl)quinazolin-4-amine

CAS: 959551-10-1

Fórmula: C₂₀H₁₄F₃N₃S

Pureza: 98%

Peso molecular: 385.41

Ref: IN-DG00791579

N-[(thiophen-2-yl)methyl]-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine

CAS: 959551-10-1

Pureza: ≥98%

Peso molecular: 385.41

Ref: 10-F980752

NIH-12848

CAS: 959551-10-1

NIH-12848 is a monoclonal antibody that binds to the factor receptor, leading to the inhibition of growth factors. It has been shown to inhibit the proliferation of chronic lymphocytic leukemia cells by preventing their growth and survival. NIH-12848 also inhibits the tyrosine kinase, reversibly inhibiting lipid kinases and leukemia cells. NIH-12848 may be used for cancer therapy or as an aid in diagnosing cancer.

Fórmula: C₂₀H₁₄F₃N₃S

Pureza: Min. 95%

Peso molecular: 385.41 g/mol

Ref: 3D-JNB55110

N-[(thiophen-2-yl)methyl]-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine

CAS: 959551-10-1

Fórmula: C₂₀H₁₄F₃N₃S

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 385.4055

Ref: IN-DA01DU9R